Migraine News | Updates | Atogepant | iPharmaCenter
AbbVie has announced the approval of Aquipta (atogepant) by the European Commission for the preventive treatment of migraine in adults...
top of page
Spinal Muscular Atrophy News | Zolgensma | Evrysdi | Spinraza | iPharmaCenter
Recent data reveals that advances in NHS treatment have substantially improved the survival rates of babies born with spinal muscular...
Alzheimer’s disease News | CHMP says no to Aduhelm | Biogen slashed the price of Aduhelm
EiSai and Biogen announced that Biologics License Application (BLA) for lecanemab received Priority Review in China. The National Medical...
Epilepsy News | Updates | iPharmaCenter
October 10, 2022 UCB plans to release Briviact in Japan with an Asian study UCB announced the Phase 3 study results of Briviact...
Neuromyelitis optica spectrum disorder | news | blogs | iPharmaCenter
October 12, 2022 AstraZeneca announced strong efficacy data of Ultomiris. AstraZeneca announced the results of the CHAMPION-NMOSD trial...
bottom of page